Regenxbio (RGNX) Cash from Operations Growth (3y) (2017 - 2025)
Regenxbio (RGNX) Cash from Operations Growth (3y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,094.26 Bn | 68,093.97 Bn | - | -5.07% |
| 2 | Nanobiotix | 1,939.09 Bn | 1,939.02 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | 33.08% |
| 5 | Vertex Pharmaceuticals | 123.34 Bn | 116.09 Bn | 2.59 Bn | 16.64% |
| 6 | Regeneron Pharmaceuticals | 70.13 Bn | 61.38 Bn | 3.31 Bn | -7.60% |
| 7 | Belite Bio | 62.96 Bn | 62.96 Bn | - | - |
| 8 | Argenx Se | 56.38 Bn | 51.20 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn | 34.32% |
| 10 | Regenxbio | 522.43 Mn | 292.36 Mn | 21.22 Mn | -9.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -9.92% |
| Sep 30, 2025 | -3.51% |
| Jun 30, 2025 | 7.20% |
| Mar 31, 2025 | 37.53% |
| Dec 31, 2024 | -27.91% |
| Sep 30, 2024 | 1.56% |
| Jun 30, 2024 | -8.04% |
| Mar 31, 2024 | -7.98% |
| Dec 31, 2023 | -44.75% |
| Sep 30, 2023 | -10.66% |
| Jun 30, 2023 | -30.09% |
| Mar 31, 2023 | -31.51% |
| Dec 31, 2022 | -15.57% |
| Sep 30, 2022 | -20.06% |
| Jun 30, 2022 | -37.51% |
| Mar 31, 2022 | -24.04% |
| Dec 31, 2021 | 338.80% |
| Sep 30, 2021 | -29.53% |
| Jun 30, 2021 | -35.97% |
| Mar 31, 2021 | -40.23% |